Product Information
METHIMAZOLE 5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0707 per EA under NDC 64380021201. Its NADAC has been published 221 times since Jun 1, 2022.
FDA first approved this application on Mar 29, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the methimazole market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380021201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA040350FDA Approved
3/29/2000
TE Code
AB
On Market Since
3/14/2022
Pharmacological Classes
Price Statistics
The NADAC for METHIMAZOLE 5 MG TABLET has been published 221 times since Jun 1, 2022, and over the history we have for it it has risen 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0707 per EA |
|---|---|
| All-time high | $0.1140 (Sep 13, 2023) |
| All-time low | $0.0602 (Jun 1, 2022) |
| 52-week high | $0.0864 |
| 52-week low | $0.0707 |
| Median price | $0.0759 |
| Average price | $0.0784 |
| Largest weekly change | +27.3% (Aug 23, 2023) |
| Weeks tracked | 221 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHIMAZOLE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by Strides Pharma Inc., is $0.0707 per EA (NDC 64380021201), effective Aug 19, 2026.
How has the price of METHIMAZOLE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has risen 17.5%. It has been tracked across 221 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?
Since Jun 1, 2022, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0602 (Jun 1, 2022) to a high of $0.1140 (Sep 13, 2023), with a median of $0.0759 per EA.
Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHIMAZOLE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHIMAZOLE 5 MG TABLET?
METHIMAZOLE 5 MG TABLET (NDC 64380021201) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.